Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kutzkey Tim
Relationship:  
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   35,728,642    

Indirect Shares

   4,162,673      
Direct Value   $434,916,061    

Indirect Value

   $124,372,793      
Total Shares   39,891,315      
Total Value   $559,288,854      


Arcus Biosciences Inc $8,213,655 Immune Design Corp. $0 Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,801,515 Revolution Medicines, Inc. $311,038,202 Arcus Biosciences Inc $8,213,655 Immune Design Corp. $0 Constellation Pharmaceuticals Inc $87,862,688 Ngm Biopharmaceuticals Inc $27,801,515 Revolution Medicines, Inc. $311,038,202
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    10   
    1    

     Stock price went up :
    8   
    0    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   4.0   
   -1.0   
     Percentage Gain/Loss :
   42.8%
 -8.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Arcus Biosciences Inc RCUS 10% Owner 2018-03-19 470,427 2018-03-19 0    Premium*  
            Immune Design Corp. IMDZ 10% Owner 2017-10-27 6,642,942 2017-10-27 0    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2021-02-17 2,584,957 2021-02-17 3,645,681    Premium*  
            Ngm Biopharmaceuticals Inc NGM Managing Partner, 10% ... 2020-09-02 18,052,932 2020-09-02 190,000    Premium*  
            Revolution Medicines, Inc. RVMD Managing Partner, 10% ... 2020-02-18 7,977,384 2020-02-18 0    Premium*  
            Surrozen Ord Shs SRZN 0 2024-04-04 326,992    Premium*  
* Premium Members only  

Records found :    57         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
IMDZ Immune Design Corp. 10% Owner   –       –       •   2017-10-27 4 B $4.10 $10,992,100 D/D 2,681,000 6,642,942 2.45 -
RCUS Arcus Biosciences Inc 10% Owner   –       –       •   2018-03-19 4 A $0.00 $0 D/D 3,540,850 470,427 0 -
CNST Constellation Pharmaceuti... 10% Owner   –       –       •   2018-07-23 4 A $0.00 $0 D/D 4,666,888 4,677,939 0 -
CNST Constellation Pharmaceuti... 10% Owner   –       –       •   2018-07-23 4 A $0.00 $0 I/I 79,155 79,155 0 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-04-08 4 A $0.00 $0 D/D 13,093,134 13,569,091 0 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-04-08 4 B $16.00 $30,240,000 D/D 1,890,000 15,000 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-05-07 4 B $14.10 $803,700 D/D 57,000 1,932,000 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-05-10 4 B $13.85 $248,234 D/D 17,923 1,949,923 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-05-20 4 B $13.50 $675,000 D/D 50,000 1,999,923 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-04 4 B $13.39 $168,764 D/D 12,600 2,012,523 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-06 4 B $13.40 $168,884 D/D 12,600 2,025,123 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-07 4 B $13.66 $172,176 D/D 12,600 2,037,723 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-11 4 B $13.83 $150,718 D/D 10,900 2,048,623 2.45 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2019-06-12 4 B $14.00 $104,989 D/D 7,500 2,056,123 2.45 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2019-06-13 4 B $14.13 $162,508 D/D 11,500 2,067,623 2.45 -
NGM Ngm Biopharmaceuticals In... General Partner   –       –       •   2019-06-14 4 B $14.00 $150,687 D/D 10,760 2,078,383 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-19 4 B $13.91 $211,674 D/D 15,214 2,093,597 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-20 4 B $13.86 $213,385 D/D 15,400 2,108,997 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-21 4 B $14.03 $52,789 D/D 3,763 2,112,760 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-06-24 4 B $13.78 $168,650 D/D 12,240 2,125,000 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-07-11 4 B $13.87 $150,752 D/D 10,870 2,135,870 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-07-12 4 B $13.88 $291,765 D/D 21,014 2,156,884 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-07-15 4 B $13.69 $221,547 D/D 16,188 2,173,072 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-07-16 4 B $13.86 $54,055 D/D 3,900 2,176,972 2.45 -
NGM Ngm Biopharmaceuticals In... Managing Partner   –       –       •   2019-07-19 4 B $13.99 $87,043 D/D 6,222 2,183,194 2.45 -
  57  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us